Gulf South Strategies Partners Meet With HHS Secretary Tom Price About The National Opioid Crisis

Share Article

Louisiana-based firm GSS leverages their close ties with the Trump Administration to highlight drug treatment and the ongoing Opioid crisis with newly confirmed HHS Secretary Tom Price.

News Image

Gulf South Strategies Senior Partners Brian Trascher and Adrian Bruneau meet with HHS Secretary Tom Price

GSS, a firm with close ties to the Trump Administration, set the meeting to offer policy guidance facing the substance abuse treatment industry and the ongoing Opioid crisis in America.

On March 27, 2017, Louisiana-based governmental relations firm Gulf South Strategies escorted their clients from Treatment Communities of America and Odyssey House of Louisiana, to the personal office of new Health and Human Services Secretary Tom Price, M.D., in Washington, D.C. GSS, a firm with close ties to the Trump Administration, set the meeting to offer policy guidance facing the substance abuse treatment industry and the ongoing opioid crisis in America.

The meeting also covered the CMS 15-day in-patient care limitations introduced by the previous administration, as well as the necessity of separating addiction from mental health classifications under the law. Secretary Price assured TCA and Odyssey House that the agency would investigate current policy challenges and seek patient-centered solutions to them that empower individuals, families and providers to make the best choices for care. GSS is optimistic that their clients in the healthcare industry will continue to develop strong, meaningful relationships with the new HHS Secretary and his team.

Two days later, President Trump announced the formation of a national commission to tackle the opioid crisis, naming New Jersey Governor Chris Christie as the leader of the new commission. GSS Principals Brian Trascher and Adrian Bruneau plan to meet with Governor Christie in the coming weeks to discuss collaborative efforts with the commission as well as offer suggestions for experts in the drug treatment industry who are willing to serve on the commission.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brian Trascher
Visit website

Media